MIRA, Alessia
 Distribuzione geografica
Continente #
NA - Nord America 197
EU - Europa 153
AS - Asia 85
AF - Africa 2
OC - Oceania 2
Totale 439
Nazione #
US - Stati Uniti d'America 193
IT - Italia 94
SG - Singapore 40
CN - Cina 20
IE - Irlanda 18
DE - Germania 14
JP - Giappone 9
SE - Svezia 9
ID - Indonesia 6
ES - Italia 5
CA - Canada 4
IN - India 4
FI - Finlandia 3
MY - Malesia 3
PL - Polonia 3
AU - Australia 2
NG - Nigeria 2
RU - Federazione Russa 2
VN - Vietnam 2
AT - Austria 1
BE - Belgio 1
CZ - Repubblica Ceca 1
FR - Francia 1
HK - Hong Kong 1
UA - Ucraina 1
Totale 439
Città #
Turin 34
Singapore 31
Chandler 24
Santa Clara 19
Dublin 18
Milan 12
Fairfield 11
Ashburn 9
Tokyo 8
Cambridge 7
Columbus 7
Munich 7
Jakarta 6
Beijing 5
Seattle 5
Torino 5
Woodbridge 5
Boston 4
Dearborn 4
Houston 4
Nyköping 4
Pisa 4
Cafasse 3
Frankfurt am Main 3
Genoa 3
Kota Kinabalu 3
Pottstown 3
Princeton 3
Abuja 2
Alessandria 2
Aversa 2
Bari 2
Düsseldorf 2
Edison 2
Florence 2
Hamburg 2
Helsinki 2
L'Olleria 2
Medford 2
Melbourne 2
Novara 2
Perugia 2
Pescara 2
San Jose 2
Shanghai 2
South Amboy 2
Toronto 2
Warsaw 2
Antwerp 1
Baltimore 1
Barcelona 1
Bergamo 1
Bethesda 1
Boardman 1
Bozeman 1
Brooklyn 1
Catania 1
Coimbatore 1
Hradec Králové 1
Kharkiv 1
Kolkata 1
Krasnoyarsk 1
Kunming 1
Lappeenranta 1
Los Angeles 1
Madrid 1
Montréal 1
Nanjing 1
New Delhi 1
Pearland 1
Perm 1
Philadelphia 1
Pune 1
San Diego 1
Upper Marlboro 1
Valencia 1
Victoria 1
Vienna 1
Wilmington 1
Wuhan 1
Xian 1
Ypsilanti 1
Totale 325
Nome #
Stroma-derived HGF drives metabolic adaptation of colorectal cancer to angiogenesis inhibitors 118
How to manage KRAS G12C-mutated advanced non-small-cell lung cancer 75
A non-dividing cell population with high pyruvate dehydrogenase kinase activity regulates metabolic heterogeneity and tumorigenesis in the intestine 75
Comparative Analysis and Isoform-Specific Therapeutic Vulnerabilities of KRAS Mutations in Non-Small Cell Lung Cancer 70
YAP and TAZ orchestrate adaptive resistance to KRAS inhibitors 46
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy 29
Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer models 24
RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade 15
Totale 452
Categoria #
all - tutte 1.890
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.890


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 1 2 3 0 0 0 1 0
2020/202130 0 0 0 9 0 0 4 0 2 10 1 4
2021/202257 3 0 0 1 1 0 1 0 2 8 34 7
2022/2023129 7 11 5 8 8 29 9 6 21 9 5 11
2023/2024104 9 9 5 12 1 9 9 6 4 9 25 6
2024/2025109 3 13 24 29 40 0 0 0 0 0 0 0
Totale 452